<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32184029</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1497</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neurobiology of aging</Title><ISOAbbreviation>Neurobiol Aging</ISOAbbreviation></Journal><ArticleTitle>A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>134</EndPage><MedlinePgn>125-134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurobiolaging.2020.02.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0197-4580(20)30038-5</ELocationID><Abstract><AbstractText>A hexanucleotide repeat expansion on chromosome 9 open reading frame 72 (C9orf72) is associated with familial amyotrophic lateral sclerosis (ALS) and a subpopulation of patients with sporadic ALS and frontotemporal dementia. We used inducible pluripotent stem cells from neurotypic and C9orf72+ (C9+) ALS patients to derive neuronal progenitor cells. We demonstrated that C9+ and neurotypic neuronal progenitor cells differentiate into neurons. The C9+ neurons, however, spontaneously re-expressed cyclin D1 after 12&#xa0;weeks, suggesting cell cycle re-engagement. Gene profiling revealed significant increases in senescence-associated genes in C9+ neurons. Moreover, C9+ neurons expressed high levels of mRNA for CXCL8, a chemokine overexpressed by senescent cells, while media from C9+ neurons contained significant levels of CXCL8, CXCL1, IL13, IP10, CX3CL1, and reactive oxygen species, which are components of the senescence-associated secretory phenotype. Thus, re-engagement of cell cycle-associated proteins and a senescence-associated secretory phenotype could be fundamental components of neuronal dysfunction in ALS and frontotemporal dementia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Porterfield</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Virginia, Charlottesville, VA, USA; University of Virginia Stem Cell Core, Office of Research Core Administration, University of Virginia, Charlottesville, VA, USA; Department of Cell Biology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Shahzad S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foff</LastName><ForeName>Erin P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koseoglu</LastName><ForeName>Mehmet Murat</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Virginia, Charlottesville, VA, USA; Department of Pharmacology, University of Virginia, Charlottesville, VA, USA; Fiske Drug Discovery Laboratory, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Isabella K</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayaraman</LastName><ForeName>Sruthi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lien</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McConnell</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA; Department of Neuroscience, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>George S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, University of Virginia, Charlottesville, VA, USA; Department of Biology, University of Virginia, Charlottesville, VA, USA; Department of Neuroscience, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazo</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA; Fiske Drug Discovery Laboratory, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharlow</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA; Fiske Drug Discovery Laboratory, University of Virginia, Charlottesville, VA, USA. Electronic address: ers7g@virginia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG063400</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG051085</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurobiol Aging</MedlineTA><NlmUniqueID>8100437</NlmUniqueID><ISSNLinking>0197-4580</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508606">CXCL8 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016922" MajorTopicYN="N">Cellular Senescence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="Y">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018507" MajorTopicYN="N">Gene Expression Regulation, Developmental</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cell cycle re-entry</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Senescence</Keyword><Keyword MajorTopicYN="N">Senescence-associated secretory phenotype</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32184029</ArticleId><ArticleId IdType="mid">NIHMS1563589</ArticleId><ArticleId IdType="pmc">PMC7166179</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.02.011</ArticleId><ArticleId IdType="pii">S0197-4580(20)30038-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW 3rd, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, 2013. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77(4), 639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM, 2018. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14(9), 544&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, Li Y, Mu Y, Chen G, Yu D, McCarthy S, Sebat J, Gage FH, 2011. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473(7346), 221&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392969</ArticleId><ArticleId IdType="pubmed">21490598</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Kiernan MC, Vucic S, Hodges JR, 2011. Motor neuron dysfunction in frontotemporal dementia. Brain 134(Pt 9), 2582&#x2013;2594.</Citation><ArticleIdList><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ, 2018. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562(7728), 578&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206507</ArticleId><ArticleId IdType="pubmed">30232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J, 2013. Aging, cellular senescence, and cancer. Annu Rev Physiol 75, 685&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4166529</ArticleId><ArticleId IdType="pubmed">23140366</ArticleId></ArticleIdList></Reference><Reference><Citation>Centeno EGZ, Cimarosti H, Bithell A, 2018. 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling. Mol Neurodegener 13(1), 27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964712</ArticleId><ArticleId IdType="pubmed">29788997</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D&#x2019;Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, Klee JB, Zhang C, Wainger BJ, Peitz M, Kovacs DM, Woolf CJ, Wagner SL, Tanzi RE, Kim DY, 2014. A three-dimensional human neural cell culture model of Alzheimer&#x2019;s disease. Nature 515(7526), 274&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366007</ArticleId><ArticleId IdType="pubmed">25307057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cingoz O, Goff SP, 2018. Cyclin-dependent kinase activity is required for type I interferon production. Proc Natl Acad Sci U S A 115(13), E2950&#x2013;E2959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5879699</ArticleId><ArticleId IdType="pubmed">29507205</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson TM, Golde TE, Lagier-Tourenne C, 2018. Animal models of neurodegenerative diseases. Nat Neurosci 21(10), 1370&#x2013;1379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6615039</ArticleId><ArticleId IdType="pubmed">30250265</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R, 2011. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2), 245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, Faden AI, 2005. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A 102(23), 8333&#x2013;8338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1149422</ArticleId><ArticleId IdType="pubmed">15923260</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, Rigo F, Bennett CF, Blackshaw S, Sattler R, Rothstein JD, 2013. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80(2), 415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabregat A, Sidiropoulos K, Garapati P, Gillespie M, Hausmann K, Haw R, Jassal B, Jupe S, Korninger F, McKay S, Matthews L, May B, Milacic M, Rothfels K, Shamovsky V, Webber M, Weiser J, Williams M, Wu G, Stein L, Hermjakob H, D&#x2019;Eustachio P, 2016. The Reactome pathway Knowledgebase. Nucleic Acids Res 44(D1), D481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702931</ArticleId><ArticleId IdType="pubmed">26656494</ArticleId></ArticleIdList></Reference><Reference><Citation>Frade JM, Ovejero-Benito MC, 2015. Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle 14(5), 712&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4418291</ArticleId><ArticleId IdType="pubmed">25590687</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A, 2018. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14(10), 576&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">30046148</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee KH, Badders N, Valentine M, Miller BL, Wong PC, Petrucelli L, Kim HJ, Gao FB, Taylor JP, 2015. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525(7567), 129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, Daughrity L, Dunmore JH, Castanedes-Casey M, Chew J, Cosio DM, van Blitterswijk M, Lee WC, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, 2013. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol 126(6), 829&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Fumagalli L, Prior R, Van Den Bosch L, 2017. Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells. Front Neurosci 11, 671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5733489</ArticleId><ArticleId IdType="pubmed">29326542</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms MB, Cady J, Zaidman C, Cooper P, Bali T, Allred P, Cruchaga C, Baughn M, Libby RT, Pestronk A, Goate A, Ravits J, Baloh RH, 2013. Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis. Neurobiol Aging 34(9), 2234 e2213&#x2013;2239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3679344</ArticleId><ArticleId IdType="pubmed">23597494</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins AM, DeSimone E, Chwalek K, Kaplan DL, 2015. 3D in vitro modeling of the central nervous system. Prog Neurobiol 125, 1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4324093</ArticleId><ArticleId IdType="pubmed">25461688</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, 2010. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med 16(11), 1210&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">21052075</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SS, LaCroix M, Boyle G, Sherman MA, Brown JL, Amar F, Aldaco J, Lee MK, Bloom GS, Lesne SE, 2018. Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons. Acta Neuropathol 136(4), 589&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329667</ArticleId><ArticleId IdType="pubmed">29995210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, O&#x2019;Sullivan ML, Sanchez CA, Hwang M, Israel MA, Brennand K, Deerinck TJ, Goldstein LS, Gage FH, Ellisman MH, Ghosh A, 2011. Investigating synapse formation and function using human pluripotent stem cell-derived neurons. Proc Natl Acad Sci U S A 108(7), 3005&#x2013;3010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041068</ArticleId><ArticleId IdType="pubmed">21278334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodis EJ, Choi S, Swanson E, Ferreira G, Bloom GS, 2018. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-beta oligomers to ectopic neuronal cell cycle reentry in Alzheimer&#x2019;s disease. Alzheimers Dement 14(10), 1302&#x2013;1312.</Citation><ArticleIdList><ArticleId IdType="pubmed">30293574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritsilis M, S VR, Koutsoudaki PN, Evangelou K, Gorgoulis VG, Papadopoulos D, 2018. Ageing, Cellular Senescence and Neurodegenerative Disease. Int J Mol Sci 19(10).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213570</ArticleId><ArticleId IdType="pubmed">30261683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling SC, Zhu Q, Polymenidou M, Drenner K, Artates JW, McAlonis-Downes M, Markmiller S, Hutt KR, Pizzo DP, Cady J, Harms MB, Baloh RH, Vandenberg SR, Yeo GW, Fu XD, Bennett CF, Cleveland DW, Ravits J, 2013. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A 110(47), E4530&#x2013;4539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Ciura S, Rouleau GA, Kabashi E, 2015. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD). Trends Genet 31(5), 263&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">25869998</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBel CP, Bondy SC, 1992. Oxidative damage and cerebral aging. Prog Neurobiol 38(6), 601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">1589582</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J, 2006. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 66(5), 2544&#x2013;2552.</Citation><ArticleIdList><ArticleId IdType="pubmed">16510571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim AC, Qi RZ, 2003. Cyclin-dependent kinases in neural development and degeneration. J Alzheimers Dis 5(4), 329&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">14624029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW, 2013. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79(3), 416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccioni RB, Munoz JP, Barbeito L, 2001. The molecular bases of Alzheimer&#x2019;s disease and other neurodegenerative disorders. Arch Med Res 32(5), 367&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">11578751</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J, Muravov O, Horton K, 2016. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012&#x2013;2013. MMWR Surveill Summ 65(8), 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">27490513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Fratta P, Isaacs AM, 2013. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol 126(6), 845&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Grasser FA, Gijselinck I, May S, Rentzsch K, Weng SM, Schludi MH, van der Zee J, Cruts M, Van Broeckhoven C, Kremmer E, Kretzschmar HA, Haass C, Edbauer D, 2013a. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 126(6), 881&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D, 2013b. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339(6125), 1335&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori S, Maher P, Conti B, 2016. Neuroimmunology of the Interleukins 13 and 4. Brain Sci 6(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931495</ArticleId><ArticleId IdType="pubmed">27304970</ArticleId></ArticleIdList></Reference><Reference><Citation>Musi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Shen Q, Orr ME, 2018. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17(6), e12840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6260915</ArticleId><ArticleId IdType="pubmed">30126037</ArticleId></ArticleIdList></Reference><Reference><Citation>Myrianthopoulos V, Evangelou K, Vasileiou PVS, Cooks T, Vassilakopoulos TP, Pangalis GA, Kouloukoussa M, Kittas C, Georgakilas AG, Gorgoulis VG, 2019. Senescence and senotherapeutics: a new field in cancer therapy. Pharmacol Ther 193, 31&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">30121319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng AS, Rademakers R, Miller BL, 2015. Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci 1338, 71&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4399703</ArticleId><ArticleId IdType="pubmed">25557955</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda M, Doi Y, Liang J, Kawanokuchi J, Sonobe Y, Takeuchi H, Mizuno T, Suzumura A, 2011. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J Biol Chem 286(3), 2308&#x2013;2319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3023525</ArticleId><ArticleId IdType="pubmed">21071446</ArticleId></ArticleIdList></Reference><Reference><Citation>Norambuena A, Wallrabe H, McMahon L, Silva A, Swanson E, Khan SS, Baerthlein D, Kodis E, Oddo S, Mandell JW, Bloom GS, 2017. mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer&#x2019;s disease. Alzheimers Dement 13(2), 152&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5318248</ArticleId><ArticleId IdType="pubmed">27693185</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor SM, Stenger DA, Shaffer KM, Ma W, 2001. Survival and neurite outgrowth of rat cortical neurons in three-dimensional agarose and collagen gel matrices. Neurosci Lett 304(3), 189&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">11343834</ArticleId></ArticleIdList></Reference><Reference><Citation>Oost W, Talma N, Meilof JF, Laman JD, 2018. Targeting senescence to delay progression of multiple sclerosis. J Mol Med (Berl) 96(11), 1153&#x2013;1166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6208951</ArticleId><ArticleId IdType="pubmed">30229272</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Wetzel I, Marriott I, Dreau D, D&#x2019;Avanzo C, Kim DY, Tanzi RE, Cho H, 2018. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer&#x2019;s disease. Nat Neurosci 21(7), 941&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800152</ArticleId><ArticleId IdType="pubmed">29950669</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelegri C, Duran-Vilaregut J, del Valle J, Crespo-Biel N, Ferrer I, Pallas M, Camins A, Vilaplana J, 2008. Cell cycle activation in striatal neurons from Huntington&#x2019;s disease patients and rats treated with 3-nitropropionic acid. Int J Dev Neurosci 26(7), 665&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">18768156</ArticleId></ArticleIdList></Reference><Reference><Citation>Piechota M, Sunderland P, Wysocka A, Nalberczak M, Sliwinska MA, Radwanska K, Sikora E, 2016. Is senescence-associated beta-galactosidase a marker of neuronal senescence? Oncotarget 7(49), 81099&#x2013;81109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5348379</ArticleId><ArticleId IdType="pubmed">27768595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Bowser R, 2003. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 162(3), 823&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868100</ArticleId><ArticleId IdType="pubmed">12598317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Bowser R, 2010. p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. Open Pathol J 4, 11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3092395</ArticleId><ArticleId IdType="pubmed">21572928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, Bland RJ, Slack RS, During MJ, Park DS, 2005. Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci U S A 102(39), 14080&#x2013;14085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1236525</ArticleId><ArticleId IdType="pubmed">16166266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashidian J, Iyirhiaro GO, Park DS, 2007. Cell cycle machinery and stroke. Biochim Biophys Acta 1772(4), 484&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">17241774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW, 2017. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18(1), 529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5708080</ArticleId><ArticleId IdType="pubmed">29187165</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL 3rd, Mackenzie IR, Petersen RC, Strong MJ, Miller BL, Boeve BF, Uitti RJ, Boylan KB, Wszolek ZK, Graff-Radford NR, Dickson DW, Ross OA, Rademakers R, 2012. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging 33(12), 2950 e2955&#x2013;2957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617405</ArticleId><ArticleId IdType="pubmed">22840558</ArticleId></ArticleIdList></Reference><Reference><Citation>Seward ME, Swanson E, Norambuena A, Reimann A, Cochran JN, Li R, Roberson ED, Bloom GS, 2013. Amyloid-beta signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer&#x2019;s disease. J Cell Sci 126(Pt 5), 1278&#x2013;1286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3635465</ArticleId><ArticleId IdType="pubmed">23345405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolowski JD, Chabanon-Hicks CN, Han CZ, Heffron DS, Mandell JW, 2014. Fractalkine is a &#x201c;find-me&#x201d; signal released by neurons undergoing ethanol-induced apoptosis. Front Cell Neurosci 8, 360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4224129</ArticleId><ArticleId IdType="pubmed">25426022</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Coppe JP, Lam EW, 2018. Cellular Senescence: The Sought or the Unwanted? Trends Mol Med 24(10), 871&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pubmed">30153969</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada LT, 2015. The Genetics of Monogenic Frontotemporal Dementia. Dement Neuropsychol 9(3), 219&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619362</ArticleId><ArticleId IdType="pubmed">29213965</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan FC, Hutchison ER, Eitan E, Mattson MP, 2014. Are there roles for brain cell senescence in aging and neurodegenerative disorders? Biogerontology 15(6), 643&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4264619</ArticleId><ArticleId IdType="pubmed">25305051</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL, 2013. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123(3), 966&#x2013;972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582125</ArticleId><ArticleId IdType="pubmed">23454759</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian DS, Peng J, Murugan M, Feng LJ, Liu JL, Eyo UB, Zhou LJ, Mogilevsky R, Wang W, Wu LJ, 2017. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1beta Production after Status Epilepticus. J Neurosci 37(33), 7878&#x2013;7892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5559763</ArticleId><ArticleId IdType="pubmed">28716963</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, Philtjens S, Vandenbulcke M, Sleegers K, Sieben A, Baumer V, Maes G, Corsmit E, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, de Mendonca A, Miltenberger-Miltenyi G, Pereira S, Pimentel J, Nacmias B, Bagnoli S, Sorbi S, Graff C, Chiang HH, Westerlund M, Sanchez-Valle R, Llado A, Gelpi E, Santana I, Almeida MR, Santiago B, Frisoni G, Zanetti O, Bonvicini C, Synofzik M, Maetzler W, Vom Hagen JM, Schols L, Heneka MT, Jessen F, Matej R, Parobkova E, Kovacs GG, Strobel T, Sarafov S, Tournev I, Jordanova A, Danek A, Arzberger T, Fabrizi GM, Testi S, Salmon E, Santens P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Philtjens S, Sleegers K, Baumer V, Maes G, Corsmit E, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Philtjens S, Theuns J, Sleegers K, Baumer V, Maes G, Cruts M, Van Broeckhoven C, Engelborghs S, De Deyn PP, Cras P, Engelborghs S, De Deyn PP, Vandenbulcke M, Vandenbulcke M, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, Synofzik M, Maetzler W, Muller Vom Hagen J, Schols L, Synofzik M, Maetzler W, Muller Vom Hagen J, Schols L, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, de Mendonca A, Miltenberger-Miltenyi G, Pereira S, Firmo C, Pimentel J, Sanchez-Valle R, Llado A, Antonell A, Molinuevo J, Gelpi E, Graff C, Chiang HH, Westerlund M, Graff C, Kinhult Stahlbom A, Thonberg H, Nennesmo I, Borjesson-Hanson A, Nacmias B, Bagnoli S, Sorbi S, Bessi V, Piaceri I, Santana I, Santiago B, Santana I, Helena Ribeiro M, Rosario Almeida M, Oliveira C, Massano J, Garret C, Pires P, Frisoni G, Zanetti O, Bonvicini C, Sarafov S, Tournev I, Jordanova A, Tournev I, Kovacs GG, Strobel T, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, Jessen F, Matej R, Parobkova E, Danel A, Arzberger T, Maria Fabrizi G, Testi S, Ferrari S, Cavallaro T, Salmon E, Santens P, Cras P, European Early-Onset Dementia C, 2013. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat 34(2), 363&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638346</ArticleId><ArticleId IdType="pubmed">23111906</ArticleId></ArticleIdList></Reference><Reference><Citation>Varvel NH, Bhaskar K, Patil AR, Pimplikar SW, Herrup K, Lamb BT, 2008. Abeta oligomers induce neuronal cell cycle events in Alzheimer&#x2019;s disease. J Neurosci 28(43), 10786&#x2013;10793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680286</ArticleId><ArticleId IdType="pubmed">18945886</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, Kaye W, 2015. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener 17(1&#x2013;2), 128&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4732418</ArticleId><ArticleId IdType="pubmed">26399278</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton CC, Zhang W, Patino-Parrado I, Barrio-Alonso E, Garrido JJ, Frade JM, 2019. Primary neurons can enter M-phase. Sci Rep 9(1), 4594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6418114</ArticleId><ArticleId IdType="pubmed">30872646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, Lin S, Shneider NA, Monaghan J, Pandey UB, Pasinelli P, Ichida JK, Trotti D, 2014. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84(6), 1213&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, Inman CL, Ogrodnik MB, Hachfeld CM, Fraser DG, Onken JL, Johnson KO, Verzosa GC, Langhi LGP, Weigl M, Giorgadze N, LeBrasseur NK, Miller JD, Jurk D, Singh RJ, Allison DB, Ejima K, Hubbard GB, Ikeno Y, Cubro H, Garovic VD, Hou X, Weroha SJ, Robbins PD, Niedernhofer LJ, Khosla S, Tchkonia T, Kirkland JL, 2018. Senolytics improve physical function and increase lifespan in old age. Nat Med 24(8), 1246&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6082705</ArticleId><ArticleId IdType="pubmed">29988130</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Lei Y, Luo J, Wang J, Zhang S, Yang XJ, Sun M, Nuwaysir E, Fan G, Zhao J, Lei L, Zhong Z, 2013. Prevention of beta-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events. Stem Cell Res 10(2), 213&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">23305945</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SJ, Kim J, Lee CS, Nam Y, 2011. Simple and novel three dimensional neuronal cell culture using a micro mesh scaffold. Exp Neurobiol 20(2), 110&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3213700</ArticleId><ArticleId IdType="pubmed">22110368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, Gupta S, Thomas MA, Hong I, Chiu SL, Huganir RL, Ostrow LW, Matunis MJ, Wang J, Sattler R, Lloyd TE, Rothstein JD, 2015. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525(7567), 56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Raina AK, Perry G, Smith MA, 2004. Alzheimer&#x2019;s disease: the two-hit hypothesis. Lancet Neurol 3(4), 219&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">15039034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, Ostrow LW, Rothstein JD, Troncoso JC, Ranum LP, 2013. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A 110(51), E4968&#x2013;4977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>